July 6, 2016 / 5:36 AM / a year ago

BRIEF-Bausch + Lomb and Nicox announce publication of LBN ophthalmic solution 0.024% phase 3 study results

July 6 (Reuters) - Nicox SA :

* Bausch + Lomb and Nicox announce publication of latanoprostene bunod (LBN) ophthalmic solution 0.024 pct phase 3 study results in American journal of ophthalmology

* Second published phase 3 trial to demonstrate significantly greater efficacy versus. Timolol maleate 0.5 pct Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below